- Australia
- /
- Medical Equipment
- /
- ASX:UBI
Universal Biosensors Second Quarter 2024 Earnings: AU$0.014 loss per share (vs AU$0.007 profit in 2Q 2023)
Universal Biosensors (ASX:UBI) Second Quarter 2024 Results
Key Financial Results
- Revenue: AU$1.63m (up 25% from 2Q 2023).
- Net loss: AU$3.79m (down by 371% from AU$1.40m profit in 2Q 2023).
- AU$0.014 loss per share (down from AU$0.007 profit in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Universal Biosensors shares are down 7.1% from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 4 warning signs for Universal Biosensors (1 shouldn't be ignored!) that you need to be mindful of.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ASX:UBI
Universal Biosensors
Through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices used in healthcare (point-of-care), wine, food, and agriculture industries in Australia, the Americas, Europe, and internationally.
Excellent balance sheet slight.